TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness

Similar documents
TITLE: Probenecid Dosing When Given with Cefazolin: Guidelines and Clinical Effectiveness

DATE: 17 July 2012 CONTEXT AND POLICY ISSUES

Title: Scoop Stretcher for Restriction of Spinal Motion: Clinical Effectiveness

TITLE: Dose of Electrical Current for Biphasic Defibrillators for Synchronous Cardioversion in Patients with Tachyarrhythmia: Guidelines

Title: Re-using the Canister Portion of Metered Dose Inhalers in a Hospital Setting: Clinical Review of Safety, Cost-Effectiveness and Guidelines

TITLE: Type of Thermometer for Inpatients: Clinical-Effectiveness and Guidelines

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations

DATE: 09 December 2009 CONTEXT AND POLICY ISSUES:

TITLE: Vacuum Boards for Spinal Motion Restriction: Clinical Effectiveness

Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review

TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines

TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines

Date: 23 June Context and policy issues:

TITLE: Memantine in Combination with Cholinesterase Inhibitors for Alzheimer s Disease: Clinical Effectiveness

TITLE: Hyperbaric Oxygen Therapy for Autism: A Review of the Clinical and Cost- Effectiveness

Title: Shortened Dental Arch and Restorative Therapies: Evidence for Functional Dentition

TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness

DATE: 04 April 2012 CONTEXT AND POLICY ISSUES

TITLE: Critical Incident Stress Debriefing for First Responders: A Review of the Clinical Benefit and Harm

Title: Ultrasound for Breast Cancer Screening: Clinical Effectiveness. Date: 4 January Context and policy issues:

TITLE: Australian Sheepskins for the Management of Pressure Ulcers: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines

TITLE: Dental Loupes for Dental Procedures: A Review of the Clinical and Cost- Effectiveness

Title: Non-Steroidal Anti-Inflammatory Drugs for Analgesia in Patients with Fracture: Evidence for Use

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines

TITLE: Cognitive Behavioural Therapy for Insomnia in Adults: A Review of the Clinical Effectiveness

TITLE: Chiropractic Interventions for Acute or Chronic Lower Back Pain in Adults: A Review of the Clinical and Cost-Effectiveness

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages

Service Line: Rapid Response Service Version: 1.0 Publication Date: October 30, 2018 Report Length: 7 Pages

Title: Prostate Specific Antigen (PSA) for Prostate Cancer Screening: A Clinical Review

TITLE: Computed Tomography: A Review of the Risk of Cancer Associated with Radiation Exposure

TITLE: Shilla and MAGEC Systems for Growing Children with Scoliosis: A Review of the Clinical Benefits and Cost-Effectiveness

This report will provide a review on the comparative clinical effectiveness and safety between intranasal triamcinolone and beclomethasone.

Catheter-associated Urinary Tract Infection (CAUTI) Toolkit

1. What is the comparative efficacy of IV lorazepam and IV diazepam for the treatment of febrile seizures in children (less than 12 years of age)?

UTI IN ELDERLY. Zeinab Naderpour

The presence of bacteria in the urine of an individual

Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital

O3_A2_A_Scientific Evidence

TITLE: Group Therapy for Adults with Axis II Disorders: A Review of Clinical Effectiveness

CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines

Research questions: What is the clinical and cost-effectiveness of PCA to manage pain in a hospital setting?

Title: Nasal Midazolam for Sedation in Pediatric Patients Prior to Invasive Procedures: Clinical Safety and Effectiveness

TITLE: Vitamin D Supplementation in the Elderly and Long-Term Care Residents: Clinical Effectiveness and Guidelines for Use

CAUTI CONFERENCE CAUTI Prevention and Appropriate Use of Indwelling Urinary Catheters in the Hospital Setting

TITLE: Fluoridated Water for Cavity Prevention: Clinical and Cost-Effectiveness and

Preventing catheter-associated urinary tract infections: The CAUTI Bundle

Service Line: Rapid Response Service Version: 1.0 Publication Date: June 12, 2018 Report Length: 5 Pages

10 5 cfu/ml logistic regression duration of catheterisation, sex,

Tied with pneumonia as the second most common type of healthcareassociated

CADTH Therapeutic Review

TITLE: Universal, Community-Based Developmental Screening Tools for Children 6 Years and Younger: A Review of Clinical Effectiveness

Catheter associated urinary tract infection within care of the elderly facilities

Describe the 2017 expectations of NPSG Effectively evaluate compliance with NPSG

TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness

3. What are the guidelines for the prevention of stroke in adults diagnosed with carotid artery atherosclerosis?

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods

CATHETER-ASSOCIATED URINARY TRACT INFECTIONS

DATE: 21 November 2012 CONTEXT AND POLICY ISSUES

TITLE: Use of Topical Anesthetics for Suturing and Circumcisions in Pediatric Patients: A Review of Clinical Effectiveness and Guidelines

Title: Immunochemical Fecal Occult Blood Tests. Date: June 15, 2007

CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL

AHRQ Safety Program for Long-term Care: HAIs/CAUTI. Training LTC Facility Staff on Catheter Insertion & Maintenance to Prevent CAUTIs

National Patient Safety Goal Preventing Catheter-Associated Urinary Tract Infections (CAUTI) 9/19/2016 1

Service Line: Rapid Response Service Version: 1.0 Publication Date: March 5, 2018 Report Length: 5 Pages

TITLE: Levothyroxine for Solid Organ Donors: A Review of the Clinical-Effectiveness and Guidelines

When should UTIs be treated in the Elderly? Shelby L. Wentworth, MS4 University of Florida College of Medicine 29 AUG 2018

Reducing CAUTI Rates in MSICU by implementing a CAUTI Bundle

TITLE: Periodic Dental Examinations for Oral Health: A Review of Clinical Effectiveness, Cost Effectiveness, and Guidelines

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms

Prevention of Important HAIs: Principle & Case Scenario in VAP/CAUTI. CPT. Pasri Maharom MD, MPH Dec 15, 2015

DATE: 10 February 2016 CONTEXT AND POLICY ISSUES

Measure Information Form

Preventing CLABSI & CAUTI Preventive Measures for Central Line Associated Bloodstream Infection & Catheter Associated UTI

There s More Than One Way to Skin a CAuTi:

TITLE: Crushed Buprenorphine or Buprenorphine-Naloxone for Opioid Dependency: A Review of the Clinical Effectiveness and Guidelines

TITLE: Pathogen Reduction Technologies for Blood Products: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Urinary Catheters. Prevalence of Infections

Title: Varenicline for Smoking Cessation. Date: June 4, Context and policy issues:

TITLE: Abuse and Misuse Potential of Dimenhydrinate: A Review of the Clinical Evidence

Catheter-Associated Urinary tract infections: What works in prevention? Anucha Apisarnthanarak, MD

Inappropriate use of urinary catheters: A prospective observational study

Title: IV Colloid Plasma Volume Expanders for Hypovolemia. Date: May 15, 2007

LINKS OF INTEREST DISCLOSURE

Catheter Associated Urinary Tract Infection

TITLE: Carotid Artery Stenting versus Carotid Endarterectomy: A Review of the Clinical and Cost-Effectiveness

Catheter-Associated Urinary Tract Infection

URINARY TRACT INFECTIONS: Focus on CA UTIs

Clinical Review Report (Sample)

TITLE: Preoperative Skin Preparation: A Review of the Clinical Effectiveness and Guidelines

DATE: 22 May 2013 CONTEXT AND POLICY ISSUES

TITLE: High Intensity Focused Ultrasound for Prostate Cancer: A Review of the Guidelines and Clinical Effectiveness

TITLE: Fluoridated Water for Cavity Prevention: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines

Catheter Associated Urinary Tract Infection

Transcription:

TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness DATE: 24 November 2008 CONTEXT AND POLICY ISSUES: Urinary tract infections (UTI) are the most common cause of nosocomial infections, causing 40% of all hospital acquired infections, 80% of which are catheter-associated urinary tract infections (CAUTI). 1,2 Although the majority of CAUTI are asymptomatic, 3 a relationship exists between symptomatic CAUTI and increased mortality in diabetic, immunocompromised, and debilitated patients. 1 For both short and long term indwelling catheters, the frequency of infection is directly related to the duration of catheterization. 3 Short term catheterization is associated with an infection risk of approximately 3% -7%, and the risk of infection for patients with long term catheterization is 3% - 10%. 3 For patients in long term care, chronic catheterization is associated with increased mortality. 3 This relationship, however, is confounded by the fact that patients with long-term indwelling catheters are more likely to have comorbid conditions and reduced mobility. 3 Risk factors associated with developing symptomatic infection include trauma to genitourinary mucosa, obstruction of the urinary catheter or drainage system, 3 and fecal incontinence. 4 For long term catheterization, it is uncertain whether catheter care can help to prevent infection, as procedures such as flushing catheters with saline and perineal care with antiseptics or antimicrobials, have been shown to be ineffective. 3 Prophylactic antimicrobials and newer catheters that incorporate antimicrobials have been developed, but the use of these agents raises concerns regarding antimicrobial resistance. 3 Maintaining a closed urinary drainage system may prevent the development of CAUTI. 1 Closed urinary drainage systems are systems in which the drainage from bladder to the collection bag is closed. 1 In a pre-connected closed system, the collection system and catheter are connected with a tamper evident seal, which prevents breaking of the closed system. 2 However, CAUTI is still reported to occur with the use of a closed system. 1 Because of the ongoing problems with Disclaimer: The Health Technology Inquiry Service (HTIS) is an information service for those involved in planning and providing health care in Canada. HTIS responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. HTIS responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging health technologies, for which little information can be found, but which may in future prove to be effective. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete and up to date, CADTH does not make any guarantee to that effect. CADTH is not liable for any loss or damages resulting from use of the information in the report. Copyright: This report contains CADTH copyright material. It may be copied and used for non-commercial purposes, provided that attribution is given to CADTH. Links: This report may contain links to other information on available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners own terms and conditions.

CAUTI and claims that closed catheter systems may reduce infection risk, it is necessary to review the evidence for the short and long term use of closed urinary catheters to determine their clinical effectiveness for reducing UTI. RESEARCH QUESTION: What is the clinical effectiveness of closed urinary catheter systems for the reduction of urinary tract infections? METHODS: A limited literature search was conducted on key health technology assessment resources, including PubMed, OVID CINAHL, The Cochrane Library (Issue 4, 2008), University of York Centre for Reviews and Dissemination (CRD) databases, ECRI, EuroScan, international health technology agencies, and a focused Internet search. Results include articles published between 2003 and November 2008, and are limited to English language publications only. No filters were applied to limit the retrieval by study type. HTIS reports are organized so that the higher quality evidence is presented first. Therefore, health technology assessment reports, systematic reviews, and meta-analyses are presented first. These are followed by randomized controlled trials (RCTs), observational studies, and evidence-based guidelines. SUMMARY OF FINDINGS: One RCT, three observational studies, and one evidence-based guideline were identified on the use of closed catheter systems for the prevention of CAUTI. No health technology assessments or systematic reviews were identified. Randomized controlled trials Leone et al. (2003) examined urinary drainage systems to compare the rate of UTI. 5 A total of 311 patients who required a urinary catheter were randomized to receive either a two-chamber drainage system (TCDS; 149 patients) or a complex closed drainage system (CCDS; 162 patients). There were no differences between the study groups in terms of baseline characteristics. Urine samples were collected and tested for bacteriuria (bacteria in the urine) at weekly intervals during catheterization, and 24 hours after removal of the catheter. The incidence of bacteriuria was similar between the groups (12/149 versus 14/162 in the TDCS and CCDS groups, respectively). The TCDS group had a significantly longer stay in the intensive care unit compared to the CCDS group (29±17 days versus 19±8 days; p<0.05), and a significantly longer catheterization duration (21.5±11days versus 15±6.3 days; p<0.05). Overall, the authors concluded that there was no difference in the rate of infection between the closed system (CCDS) and TCDS. Observational studies A recent prospective study examined CAUTIs in five Japanese hospitals to determine risk factors and catheter care practice. 4 A total of 555 patients who were catheterized (using closed drainage systems or pre-connected closed systems) for three or more days were included in the study. The rate of CAUTI was 3.9/1000 device-days. Using a non-preconnected closed system was identified as a risk factor for CAUTI. A multivariate analysis found the relative risk of CAUTI Closed Catheter Systems for Prevention of Urinary Tract Infections 2

with use of a non-preconnected closed system was 2.35. The authors concluded that the incidence of CAUTI could be reduced by 50% with the use of a pre-connected closed system and daily cleansing of the perineal area. Pre-connected closed urinary catheter systems were compared with traditional bag and catheter systems in a 2005 study. 2 It is unclear whether the traditional system in this study was a closed system. The baseline group used the traditional system (n=104) between October 2002 and March 2003. The pre-connected system was later introduced, and there were 104 patients in the intervention group that used the pre-connected system between September 2003 and March 2004. There were 37.8 cases of CAUTI per 1000 catheter days in the baseline group, and 22.4 cases of CAUTI per 1000 catheter days in the intervention group. The intervention group had a 41% lower rate of CAUTI than the baseline group. This study suggested that the pre-connected system protects against CAUTI. There are limitations to these results as the groups were not studied at the same time, so other factors may have contributed to the lower rate of CAUTI. Closed urinary drainage system (CUDS) use was evaluated in a 2004 study. 6 Databases of hospitalized patients in acute care in Spanish hospitals were searched and data was collected from a chart review to determine the usage of CUDS. There were 76,788 patients included. This study found a 23.5% increase in the portion of patients using CUDS (56.5% in 1990 versus 69.8% in 2000). The prevalence of UTI decreased from 9.2% to 5.6%, which correlated with the increase in CUDS use. Evidence-based guidelines European and Asian guidelines on the management and prevention of catheter-associated UTIs were published in 2008. 7 The authors systematically searched the literature for randomized controlled trials on CAUTI. The guidelines focused on methods of catheterization, urine drainage, prevention of bacteriuria, and treatment of bacteriuria. The guidelines stated that the catheter system should remain closed (Grade of A; based on good quality clinical studies; including at least one RCT). No other mention of closed catheters was included in these guidelines. Limitations There was limited information on the use of closed urinary drainage systems identified. No health technology assessments or systematic reviews were found. There was only one RCT published in 2003 that was identified. 5 The other studies that were identified were observational studies, which are subject to potential selection bias and are unable to control for confounding factors. None of these studies evaluated the clinical effectiveness of closed catheter systems based on duration of catheterization. Both groups in one of the observational studies used a closed system (pre-connected and nonpreconnected) so the clinical effectiveness of using a closed system cannot be determined. 4 No control group was included in one observational study, and therefore, other factors may have contributed to the reduced CAUTI rate. 6 Furthermore, the other observational study compared a pre-connected system to a traditional system, and it is unclear whether the traditional system was closed. Closed Catheter Systems for Prevention of Urinary Tract Infections 3

The RCT was conducted in France 5 and the observational studies were from Japan 4, Spain 6, and the UK 2 ; therefore it is unclear whether these studies would be generalizable to a Canadian population. Furthermore, no North American guidelines were identified. CONCLUSIONS AND IMPLICATIONS FOR DECISION OR POLICY MAKING: The evidence for the clinical effectiveness of closed catheter systems is limited. Although the RCT suggested that bacteriuria incidence was similar between a closed system and a twochamber drainage system, one observational study suggested that CAUTI was reduced with use of closed systems. This evidence must be interpreted with caution, however, as there were limitations to these studies. The use of a pre-connected urinary catheter system appears to reduce CAUTI, but it may be the preconnected feature of the system and not the closed feature that is relevant. The low quality of the available evidence must be considered when deciding whether to used closed urinary drainage systems over other types of urinary catheters for the prevention of UTI. Other interventions such as perineal and catheter care, should also be considered. PREPARED BY: Lesley Dunfield, PhD, Interim Manager Kristen Moulton, BA, Research Assistant Carolyn Spry, MLIS, Information Specialist Health Technology Inquiry Service Email: htis@cadth.ca Tel: 1-866-898-8439 Closed Catheter Systems for Prevention of Urinary Tract Infections 4

REFERENCES: 1. Ha US, Cho YH. Catheter-associated urinary tract infections: new aspects of novel urinary catheters. Int J Antimicrob Agents 2006;28(6):485-90. 2. Madeo M, Barr B, Owen E. A study to determine whether the use of a preconnect urinary catheter system reduces the incidence of nosocomial urinary tract infections. Br J Infect Control 2005;6(4):22-5. 3. Nicolle LE. Catheter-related urinary tract infection. Drugs Aging 2005;22(8):627-39. 4. Tsuchida T, Makimoto K, Ohsako S, Fujino M, Kaneda M, Miyazaki T, et al. Relationship between catheter care and catheter-associated urinary tract infection at Japanese general hospitals: a prospective observational study. Int J Nurs Stud 2008;45(3):352-61. 5. Leone M, Garnier F, Antonini F, Bimar MC, Albanese J, Martin C. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Med 2003;29(4):551-4. 6. Allepuz-Palau A, Rosselló-Urgell J, Vaqué-Rafart J, Hermosilla-Pérez E, Arribas- Llorente JL, Sánchez-Payá J, et al. Evolution of closed urinary drainage systems use and associated factors in Spanish hospitals. J Hosp Infect 2004;57(4):332-8. 7. Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31 Suppl 1:S68-S78. Closed Catheter Systems for Prevention of Urinary Tract Infections 5